Effect of eicosapentaenoic acid on the platelet aggregation and composition of fatty acid in man. A double blind study. (Record no. 6307246)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01425 a2200433 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250512205634.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 198308s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0021-9150 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/0021-9150(83)90073-4 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Nagakawa, Y |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19830811 |
245 00 - TITLE STATEMENT | |
Title | Effect of eicosapentaenoic acid on the platelet aggregation and composition of fatty acid in man. A double blind study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Atherosclerosis |
Date of publication, distribution, etc. | Apr 1983 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 71-5 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Comparative Study; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anticoagulants |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Arachidonic Acids |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clinical Trials as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Eicosapentaenoic Acid |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fatty Acids, Unsaturated |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypolipidemic Agents |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lipids |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Placebos |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Platelet Aggregation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Orimo, H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Harasawa, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Morita, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yashiro, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Murota, S |
773 0# - HOST ITEM ENTRY | |
Title | Atherosclerosis |
Related parts | vol. 47 |
-- | no. 1 |
-- | p. 71-5 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/0021-9150(83)90073-4">https://doi.org/10.1016/0021-9150(83)90073-4</a> |
Public note | Available from publisher's website |
No items available.